Sweet Syndrome: A Review of Published Cases

Dermatology. 2023;239(4):664-669. doi: 10.1159/000530519. Epub 2023 Apr 5.


Sweet syndrome (SS), the prototypical neutrophilic dermatosis, is characterized by abrupt onset of tender plaques and nodules, classically accompanied by fever and leukocytosis. While management mainly relies on systemic corticosteroids, inadequate response can be seen in some patients that necessitates exploring other treatment options. Early diagnosis of malignancy-associated SS (MA-SS) along with detection of concomitant malignancy is crucial for improving patients' outcomes. Data regarding various clinical manifestations, extracutaneous associations, treatment, and outcomes are poorly characterized in the literature. We aimed to review all published case reports and case series to portray clinical features of SS including extracutaneous manifestations. We also describe reported treatment options and their outcomes to draw attention toward unmet therapeutic needs in the management of SS. In addition, for clinical and practical purposes, we attempted to delineate the distinction between MA-SS and nonmalignant subtypes of SS.

Keywords: Neutrophilic dermatoses; Sweet syndrome.

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Fever
  • Humans
  • Leukocytosis
  • Neoplasms* / drug therapy
  • Sweet Syndrome* / complications
  • Sweet Syndrome* / diagnosis
  • Sweet Syndrome* / drug therapy


  • Adrenal Cortex Hormones